Open today, a new exhibition at Paris’s Galerie Kugel displays the enamel vessels beloved by royals and Rothschilds alike.

In 2018, the Morgan Library & Museum was mounting a major Hujar exhibition ... Page 9: Hujar describes his portrait session with Ginsberg, who sat in a downtown doorway in the lotus position and ...

There is only one thing missing from Lincoln Center Theater’s (LCT) superlative Broadway revival of the musical Ragtime: a ...

When biographer Amanda Vaill read Ron Chernow’s Alexander Hamilton (2004), her first thought, she said in a recent interview, ...

West’s book is a gleaming, smart satire on the lush and brilliant days of Edward VII, more particularly of the “fast” set that clustered around the throne. In the comparatively short interval between ...

J.P. Morgan Chase CEO Jamie Dimon said the bank’s new headquarters at 270 Park Avenue in Midtown Manhattan cost about $4 ...

JP Morgan Chase & Co. (NYSE:JPM) shares are trading higher on Monday. The company introduced a $1.5 trillion 10-year Security and Resiliency Initiative. Under this program, the bank will make direct ...

Woolworths shares have declined by 14% this year. JP Morgan's price target of $29.60 indicates a possible 13% upside from the current $26.21 price. Woolworths is currently considered more attractively ...

Oct 6 (Reuters) - J.P. Morgan upgraded its stance on the euro zone to "overweight" from "neutral" on Monday, noting that the equities in the region have become more attractive after several months of ...

JP Morgan, the largest bank in the US, has named Irishman Conor Hillery as co-chief executive of the group’s operations across Europe, Middle East and Africa (EMEA). Mr Hillery, son of the late ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is one of the best biotech stocks with high potential. On September 23, J.P. Morgan analyst Anupam Rama maintained a bullish stance on IDEAYA Biosciences, Inc.